A clinician has either used the words and you are frightened by them, or has carefully avoided them while describing everything they mean, and you have come home to find out which situation you are in. Both happen constantly, and the second one is not the safer of the two.

The short answer: yes. The diagnostic manual permits a personality disorder diagnosis before 18 where the features have been present for at least a year and are not better explained by a developmental stage or another disorder — antisocial personality disorder is the single exception, which requires age 18. Australia's national guideline states it outright: after appropriate assessment, make the diagnosis in a person aged 12 to 18 who meets criteria, and do not apply the criteria to prepubescent children. The evidence supports it: adolescent BPD shares the same correlates as adult BPD, predicts long-term functional impairment, and there are randomised trials of treatment in teenagers. The counter-argument — that the label harms — is made seriously in the peer-reviewed literature and deserves an honest hearing rather than dismissal. What almost nobody argues is that a young person should be left with the symptoms and no name and no treatment.¹ ² ³ ⁴

What the rule actually is

The manual permits personality disorder categories to be applied to children or adolescents in the relatively unusual cases where the traits appear pervasive, persistent, and unlikely to be limited to a developmental stage or an episode of another mental disorder — and requires that, under 18, the features have been present for at least one year.¹

Two consequences worth holding on to:

  • Antisocial personality disorder is the only one that cannot be diagnosed under 18. BPD is not excluded.
  • The one-year duration is the gate. A bad six months after a breakup, a bereavement, or a first psychotic episode is not this diagnosis, and a careful assessment is partly an assessment of duration.

Published descriptions of the current criteria put it the same way: BPD in adolescents is "a 1-year pattern of immature personality development" across the same nine domains as in adults, and "the key diagnostic criterion is the 1-year duration of symptoms."²

What the guidelines say

Australia's national guideline is the most explicit anywhere, and it is the document to bring to an appointment where the diagnosis is being avoided:³

Recommendation 4: "Health professionals should consider assessment for BPD in people aged 12–18 years with any of the following: frequent suicidal or self-harming behaviour · marked emotional instability · multiple co-occurring psychiatric conditions · non-response to established treatments for current psychiatric symptoms · a high level of functional impairment."

Recommendation 5: "After appropriate assessment, health professionals should make the diagnosis of BPD in a person aged 12–18 years who meets the diagnostic criteria. The diagnostic criteria for BPD should not generally be applied to prepubescent children."

Its supporting text goes further: "current evidence shows that diagnostic criteria for BPD in a person under 18 years are as reliable and valid as in adults, and the diagnosis is similarly stable over time as for adults."³

And — to the guideline's credit — it records its own dissent: "Not all members of the Committee agreed with this recommendation. The alternative view was that the term 'BPD features' should be used instead of 'BPD' for people under 18 years."³

The UK guideline does not contain an explicit "you may diagnose under 18" recommendation, but it assumes throughout that the diagnosis is made in that age group and managed in child and adolescent services: young people with the diagnosis "should have access to the full range of treatments and services recommended in this guideline, but within children and adolescent mental health services," and a person under 18 who repeatedly self-harms should be referred to those services for assessment.⁴

What the evidence says about the diagnosis in teenagers

The honest version has two halves that sound contradictory and are not.

Categorical stability is low to moderate. A systematic review of 18 studies found that "the diagnostic stability of BPD prior to the age of 19 years was low to moderate" — meaning a substantial share of adolescents who meet the threshold will not meet it a few years later.⁵ In a two-year study of 101 outpatients aged 15 to 18, 74 percent of those with any personality disorder diagnosis still met criteria for one at follow-up, and borderline was in the moderate band for dimensional stability.⁶

Dimensional stability and predictive validity are good. The same review found "mean-level and rank-order stability, moderate to high," and that "individuals with BPD symptoms in childhood or adolescence had significant social, educational, work and financial impairment in later life."⁵ Its conclusion: the findings "provide some support for the clinical utility of the BPD phenotype in younger populations, and suggest that an early intervention approach may be warranted."⁵

The underlying correlates are the same as in adults. A meta-analysis of 61 studies found youth BPD associated with sexual abuse (odds ratio 4.88), physical abuse (2.79), maternal hostility or verbal abuse (3.28), neglect (3.40), comorbid mood disorder (3.21), self-harm (2.81) and suicide attempt (2.10), concluding that "adult and youth BPD share common aetiological and psychopathological correlates."⁷

How common is it? Around 3 percent of the general adolescent population by published estimates, rising to about 11 percent in adolescents attending an outpatient clinic and far higher among adolescents presenting to emergency departments after a suicide attempt.² The most recent research review holds that "evidence supports diagnosing BPD in adolescents from the age of 12 years, with validated diagnostic measures available."⁸

So: many adolescents who meet criteria will not meet them at 22 — and meeting them at 16 still predicts real difficulty at 30. Both are true. What follows from both is the same thing: assess properly and treat now.

The argument against, taken seriously

This is a live debate in the journals, not a fringe position, and a parent deserves to see it stated rather than editorialised away.

The case that the label harms. A group of clinicians, researchers and people with lived experience wrote that "there is a wealth of evidence to suggest that the Borderline Personality Disorder… construct is harmful," and argue that it is "invalid, harmful, not necessary for effective treatment and a potential block to the development and evaluation of alternatives."⁹ A qualitative study of thirteen English child and adolescent clinicians found themes of "Who holds the power?" and "The weightiness of making this decision."¹⁰ And the Australian guideline itself acknowledges that "some health professionals have preferred to withhold the diagnosis, even when confident of its accuracy, due to concerns about stigma and discrimination the person may experience as a result of the BPD label."³

The case that withholding it harms. Also stated plainly: "The current reluctance of clinicians to use this diagnosis in younger age groups obstructs the correct choice of treatment options for young people. Not diagnosing PD at an early stage means to deprive adolescents of effective treatments, thus increasing their risk of fatal outcome."¹¹ Another: "Deliberate misdiagnosis of Personality Disorder due to professionals' unwillingness to use the diagnosis is not only unethical but can also cause harm as it stops young people from receiving the evidence-based interventions and support that they require. Young people and families often experience reassurance and relief when they receive an accurate diagnosis."¹² And a group including one of the field's leading early-intervention researchers argues that "early detection and intervention might have anti-stigmatizing effects, similar to other areas of healthcare in which stigmatizing labels have changed meaning when the conditions to which they refer have become more amenable to treatment."¹³

What the small amount of direct evidence on disclosure shows: in 21 adolescents interviewed about a month after being told, responses varied widely, and "patients tended to view the diagnosis as an accurate representation of their symptoms."¹⁴ Small, uncontrolled, and the only thing of its kind we found.

A reasonable position for a parent, holding all of that: the label is not the treatment, and the question worth pressing is not "will you write BPD in the chart" but "what are you going to do, and does it match what the trials tested."

What treatment in adolescents actually shows

Randomised evidence exists, and it is specific about what improves.

DBT for adolescents. Seventy-seven adolescents with recent, repeated self-harm were randomised to nineteen weeks of DBT-A or enhanced usual care. DBT-A was superior on self-harm, suicidal ideation and depression, with large effect sizes.¹⁵ At one year, "DBT-A remained superior to EUC in reducing the frequency of self-harm," while the differences on ideation, hopelessness, depression and borderline symptoms had gone — because the comparison group caught up.¹⁶ At three years, the same pattern held: still superior on self-harm frequency, no differences elsewhere, no relapse in either group.¹⁷

A second, independent DBT trial. One hundred and seventy-three adolescents aged 12 to 18 with a prior suicide attempt, randomised to six months of DBT or individual and group supportive therapy. DBT was superior after treatment on suicide attempts, non-suicidal self-injury and self-harm; by six to twelve months of follow-up the between-group difference was no longer significant. On the strength of two independent trials, the authors describe DBT as "the first well-established, empirically supported treatment for decreasing repeated suicide attempts and self-harm in youths."¹⁸

Mentalization-based treatment for adolescents. Eighty adolescents with self-harm and depression, randomised to a year of MBT-A or usual care: "MBT-A was more effective than TAU in reducing self-harm and depression."¹⁹

The service model may matter as much as the therapy brand. In a three-arm trial of 139 young people, a dedicated youth-oriented BPD service was compared with a general youth mental health service, and specialist psychotherapy with a befriending control. Everyone improved 19 to 24 percent on the primary outcomes, and "neither the service model nor the psychotherapy intervention was associated with a superior rate of change in psychosocial functioning." What the dedicated service did do was keep young people in treatment — a median of 22 contacts against 3, and 47.8 percent completing treatment against 19.2 percent. The authors: "effective early intervention was not reliant on availability of specialist psychotherapy but did require youth-oriented clinical case management and psychiatric care."²⁰

And the pooled picture, which is the honest headline. A meta-analysis of 12 randomised trials and 844 adolescents found small significant effects on BPD symptom severity (SMD −0.27), emotion regulation difficulties (−0.26) and general psychopathology (−0.34), and no significant effect on depressive symptoms or quality of life, with "progressive erosion of treatment gains over 12–36 months."²¹ Real, modest, and needing follow-through rather than a single course.

What to do next, as a parent

  • Ask for a structured assessment, not an impression. The quality standard asks for one, and BPD is under-detected without it.²² A diagnosis made during an emergency presentation should be revisited afterwards.²³
  • Ask about duration explicitly. The one-year rule is the gate; a clinician who has not asked about it has not applied the criteria.¹
  • Ask what treatment follows, in components. For DBT-A, that means individual therapy, a skills group your family may be asked to attend, coaching between sessions, and a therapist consultation team. The four components → · The printable programme check →
  • Ask what gets measured, and when. Self-harm frequency is the outcome that held up longest in the trials; mood and hopelessness improved in both arms.¹⁵ ¹⁶ ¹⁷
  • Expect to be involved, and ask how. Family programmes exist and have their own evidence. Loving someone with BPD →
  • Know the California specifics. Minors have their own consent and confidentiality rules here, and what a therapist may tell you is not the same at 12, 15 and 17. Consent and privacy for California teens → · What a therapist can tell your parents →
  • If a higher level of care is being discussed, the questions to ask before agreeing to a residential placement are specific and worth having in advance. Check a residential programme → · PHP and IOP access →
  • If your teenager refuses to go, that is a common starting point rather than the end of the road. When a teen refuses therapy →

Q&A

Q: Can BPD be diagnosed before 18? A: Yes, where the features have been present for at least a year and are not better explained by a developmental stage or another disorder.¹ Australia's national guideline recommends making the diagnosis in 12- to 18-year-olds who meet criteria and not applying the criteria to prepubescent children.³

Q: Won't the label follow my child around? A: It is in a medical record, like any diagnosis, and stigma about this one is documented. Against that: the diagnosis is what routes a young person to treatments that have randomised evidence, and the alternative in practice is often several years of treatments aimed at the wrong target. Both harms are real; only one of them is reduced by waiting.⁹ ¹¹ ¹²

Q: Isn't this just normal teenage intensity? A: That is exactly what the one-year duration requirement, and the requirement that the pattern not be limited to a developmental stage, are there to exclude.¹ It is also what a structured assessment is for.

Q: What if the clinician says "traits" or "features" instead? A: That is a recognised position, and it was the dissenting view recorded inside the Australian guideline itself.³ The practical question to ask is whether the treatment offered is the one with evidence for BPD — because "features" with a BPD treatment plan is a different situation from "features" with nothing attached.

Q: Will they be on medication? A: Guidelines do not support medication for BPD itself at any age, and the evidence in adolescents is thinner still — the Cochrane review of drug treatment notes its findings "may not be applicable for adolescent populations."²⁴ The medication answer →

Q: Does it go away? A: A substantial share of adolescents who meet criteria will not meet them years later, and in adults the long-term follow-up data are more hopeful than almost anyone is told.⁵ What sixteen years of follow-up found →

Ready to find someone who assesses and treats adolescents properly? Filter therapists by approach, schedule and payment route → · The full BPD map → · Helping a young person who does not want help →

In crisis? Call or text 988 — free, 24/7.

Sources

  1. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders," on applying personality disorder categories to children and adolescents and the one-year duration requirement, quoted in Larrivée MP, "Borderline personality disorder in adolescents: the He-who-must-not-be-named of psychiatry," Dialogues in Clinical Neuroscience 15(2), 2013, 171–179 — "To diagnose a personality disorder in an individual under 18 years of age, the features must have been present for at least one year" — pmc.ncbi.nlm.nih.gov.
  2. Guilé JM, Boissel L, Alaux-Cantin S, de La Rivière SG, "Borderline personality disorder in adolescents: prevalence, diagnosis, and treatment strategies," Adolescent Health, Medicine and Therapeutics 9, 2018, 199–210 — "The key diagnostic criterion is the 1-year duration of symptoms"; "the prevalence of BPD in the general population of adolescents is around 3%. The clinical prevalence of BPD ranges from 11% in adolescents consulting at an outpatient clinic to 78% in suicidal adolescents attending an emergency department" — pmc.ncbi.nlm.nih.gov.
  3. National Health and Medical Research Council, "Clinical practice guideline for the management of borderline personality disorder," Melbourne, 2012 — recommendations 4 and 5, the supporting discussion on reliability and validity under 18, the recorded committee dissent, and the acknowledgement that some professionals withhold the diagnosis over stigma — nhmrc.gov.au.
  4. National Institute for Health and Care Excellence, "Borderline personality disorder: recognition and management," clinical guideline CG78 — recommendations 1.1.1.2 and 1.2.1.1 on young people and child and adolescent mental health services — nice.org.uk.
  5. Winsper C, Marwaha S, Lereya ST, Thompson A, Eyden J, Singh SP, "Clinical and psychosocial outcomes of borderline personality disorder in childhood and adolescence: a systematic review," Psychological Medicine 45(11), 2015, 2237–2251 — "the diagnostic stability of BPD prior to the age of 19 years was low to moderate, and mean-level and rank-order stability, moderate to high. Individuals with BPD symptoms in childhood or adolescence had significant social, educational, work and financial impairment in later life" — doi.org.
  6. Chanen AM, Jackson HJ, McGorry PD, Allot KA, Clarkson V, Yuen HP, "Two-year stability of personality disorder in older adolescent outpatients," Journal of Personality Disorders 18(6), 2004, 526–541 — "Of those with a categorical PD diagnosis at baseline, 74% still met criteria for a PD at follow-up"; "Diagnosis and early intervention appears to be justified in this age group" — doi.org.
  7. Winsper C, Lereya ST, Marwaha S, Thompson A, Eyden J, Singh SP, "The aetiological and psychopathological validity of borderline personality disorder in youth: a systematic review and meta-analysis," Clinical Psychology Review 44, 2016, 13–24 — 61 studies; pooled odds ratios for sexual abuse 4.88, physical abuse 2.79, maternal hostility 3.28, neglect 3.40; "adult and youth BPD share common aetiological and psychopathological correlates" — doi.org.
  8. Kaess M, Cavelti M, "Research review: what we have learned about early detection and intervention of borderline personality disorder," Journal of Child Psychology and Psychiatry 66, 2025, 1829–1848 — "Evidence supports diagnosing BPD in adolescents from the age of 12 years, with validated diagnostic measures available" — doi.org.
  9. Hartley S, Baker C, Birtwhistle M, et al., "Commentary: bringing together lived experience, clinical and research expertise," Child and Adolescent Mental Health 27(3), 2022, 246–249 — "We outline evidence that the BPD construct is invalid, harmful, not necessary for effective treatment and a potential block to the development and evaluation of alternatives" — doi.org.
  10. Papadopoullos R, Fisher P, Leddy A, Maxwell S, Hodgekins J, "Diagnosis and dilemma: clinician experiences of the use of 'borderline personality disorder' diagnosis in children and adolescents," Personality and Mental Health 16(4), 2022, 300–308 — pmc.ncbi.nlm.nih.gov.
  11. Schmeck K, "Debate: should CAMHs professionals be diagnosing personality disorder in adolescents — 'No rationale to deprive adolescents of effective treatment'," Child and Adolescent Mental Health 27(2), 2022, 192–193 — "Not diagnosing PD at an early stage means to deprive adolescents of effective treatments, thus increasing their risk of fatal outcome" — doi.org.
  12. Kingsley D, "Debate: child and adolescent mental health professionals have a responsibility to diagnose personality disorder," Child and Adolescent Mental Health 27(2), 2022, 196–198 — "Deliberate misdiagnosis of Personality Disorder due to professionals' unwillingness to use the diagnosis is not only unethical but can also cause harm" — doi.org.
  13. Hutsebaut J, Clarke SL, Chanen AM, "The diagnosis that should speak its name: why it is ethically right to diagnose and treat personality disorder during adolescence," Frontiers in Psychiatry 14, 2023, 1130417 — "early detection and intervention might have anti-stigmatizing effects" — pmc.ncbi.nlm.nih.gov.
  14. Courtney DB, Makinen J, "Impact of diagnosis disclosure on adolescents with borderline personality disorder," Journal of the Canadian Academy of Child and Adolescent Psychiatry 25(3), 2016, 177–184 — 21 adolescents; "We found wide variability in responses. Patients tended to view the diagnosis as an accurate representation of their symptoms" — pmc.ncbi.nlm.nih.gov.
  15. Mehlum L, Tørmoen AJ, Ramberg M, et al., "Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior: a randomized trial," Journal of the American Academy of Child and Adolescent Psychiatry 53(10), 2014, 1082–1091 — 77 adolescents; "DBT-A was superior to EUC in reducing self-harm, suicidal ideation, and depressive symptoms" — doi.org.
  16. Mehlum L, Ramberg M, Tørmoen AJ, et al., "Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up," Journal of the American Academy of Child and Adolescent Psychiatry 55(4), 2016, 295–300 — doi.org.
  17. Mehlum L, Ramleth RK, Tørmoen AJ, et al., "Long term effectiveness of dialectical behavior therapy versus enhanced usual care for adolescents with self-harming and suicidal behavior," Journal of Child Psychology and Psychiatry 60(10), 2019, 1112–1122 — "At the 3-year follow-up DBT-A remained superior to EUC in reducing the frequency of self-harm" — doi.org.
  18. McCauley E, Berk MS, Asarnow JR, et al., "Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial," JAMA Psychiatry 75(8), 2018, 777–785 — 173 participants; "results support DBT as the first well-established, empirically supported treatment for decreasing repeated suicide attempts and self-harm in youths" — pmc.ncbi.nlm.nih.gov.
  19. Rossouw TI, Fonagy P, "Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial," Journal of the American Academy of Child and Adolescent Psychiatry 51(12), 2012, 1304–1313 — 80 adolescents; "MBT-A was more effective than TAU in reducing self-harm and depression" — doi.org.
  20. Chanen AM, Betts JK, Jackson H, et al., "Effect of 3 forms of early intervention for young people with borderline personality disorder: the MOBY randomized clinical trial," JAMA Psychiatry 79(2), 2022, 109–119 — 139 randomised; "neither the service model nor the psychotherapy intervention was associated with a superior rate of change in psychosocial functioning"; treatment attendance median 22 against 3 contacts and completion 47.8% against 19.2%; "effective early intervention was not reliant on availability of specialist psychotherapy but did require youth-oriented clinical case management and psychiatric care" — pmc.ncbi.nlm.nih.gov.
  21. Cai M, Song X, Tong J, "Efficacy of psychological interventions for adolescents with borderline personality disorder: a systematic review and meta-analysis," Frontiers in Psychiatry 17, 2026, 1833555 — 12 randomised trials, 844 adolescents; BPD symptom severity SMD −0.27, emotion regulation −0.26, general psychopathology −0.34; no significant effects on depressive symptoms or quality of life; "progressive erosion of treatment gains over 12–36 months" — doi.org.
  22. National Institute for Health and Care Excellence, "Personality disorders: borderline and antisocial," quality standard QS88, quality statement 1, 2015 — nice.org.uk.
  23. National Institute for Health and Care Excellence, clinical guideline CG78, recommendation 1.3.6.1 — nice.org.uk.
  24. Stoffers-Winterling JM, Storebø OJ, Pereira Ribeiro J, et al., "Pharmacological interventions for people with borderline personality disorder," Cochrane Database of Systematic Reviews 11, 2022, CD012956 — "these results may not be applicable for adolescent populations" — pmc.ncbi.nlm.nih.gov.

Paid for by participating therapists. Inclusion is computed from availability data — never purchased. No ads, no data sold.